You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Jul 27, 2026; less than a full year is stored.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LTGRW
this stock
Long Table Growth Corp.
|
$229.31M | — | — | — | — |
|
VYLR
Vylor Inc.
|
$48.01B | — | — | — | 2.2% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$650.38M | +3.3% | — | — | 0.0% |
|
CCXI
Churchill Capital Corp XI
|
$627.18M | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LTGRW | -14.5% | -20.0% | — | +0.1% | — |
| SPY | -1.7% | -2.9% | +1.9% | -0.5% | +10.3% |
| vs SPY | -12.8% | -17.1% | — | +0.5% | — |
